Press Releases

Lexicon Pharmaceuticals Announces Positive Topline Phase 1 Data for LX9211	Dec 05, 2019
Lexicon Pharmaceuticals Completes Safety Review of Initial Safety Run-in Cohort of Tele-ABC Study, a Phase 2 Clinical Study of Telotristat Ethyl in Biliary Tract Cancer	Dec 03, 2019
Lexicon Pharmaceuticals Receives Formal Dispute Resolution Request Decision from FDA’s Office of New Drugs for Sotagliflozin in Type 1 Diabetes	Dec 02, 2019
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference	Nov 26, 2019
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference	Nov 14, 2019
Lexicon Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides a Business Update	Nov 07, 2019
Lexicon Pharmaceuticals to Host Third Quarter 2019 Financial Results Conference Call and Webcast on November 7, 2019	Nov 01, 2019
Lexicon Pharmaceuticals Announces Poster Presentations at the NANETS Annual Multidisciplinary NET Medical Symposium	Oct 02, 2019
Lexicon Pharmaceuticals Announces Termination of Alliance and Settlement with Sanofi	Sep 10, 2019
Lexicon Pharmaceuticals to Present Sotagliflozin Clinical Data at the European Association for the Study of Diabetes 55th Annual Meeting	Sep 10, 2019